New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.
D000328:Adult; D000368:Aged; D001201:Ascites / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D001688:Biological Products / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000150:complications / Q000276:immunology* / Q000401:mortality; D007420:Intestine, Large; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010844:Picibanil / Q000009:adverse effects / Q000627:therapeutic use*; D011379:Prognosis; D012882:Skin Tests; D013274:Stomach Neoplasms / Q000150:complications / Q000276:immunology* / Q000401:mortality; D013601:T-Lymphocytes / Q000276:immunology
D001688:Biological Products; D010844:Picibanil